INTERNATIONAL PATENT: PHARMAESSENTIA CORPORATION, LIN, KO-CHUNG FILES APPLICATION FOR "COMPOSITION AND METHOD OF TREATING T-CELL LYMPHOMA"

GENEVA, Jan. 6 -- PHARMAESSENTIA CORPORATION (13F, No. 3, Park StreetNangang DistrictTaipei 115), LIN, Ko-Chung (253 Lincoln StreetLexington, MA 02421) filed a patent application (PCT/US2025/034808) for "COMPOSITION AND METHOD OF TREATING T-CELL LYMPHOMA" on Jun 23, 2025. With publication no. WO/2026/006187, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAMPSON, Erik (36 Crosby DriveSuite 202Bedford, MA 01730)

Abstract: Disclosed herein is a compound that has properties to treat a subject with T cell lymphoma as compar...